For most of Europe, generic drugs have hardly been worth thinking about. Reimbursement systems set single prices for any chemical entity, branded or otherwise. Generics, whose only marketable differentiation is that they can sell for lower prices, had no place in this world.
Until, that is, countries like Germany and the UK recognized the cost savings generics could bring to their drug budgets....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?